Bank of America’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.1M Buy
650,222
+202,465
+45% +$2.83M ﹤0.01% 2834
2025
Q1
$6.09M Buy
447,757
+177,424
+66% +$2.41M ﹤0.01% 3056
2024
Q4
$5.51M Sell
270,333
-77,831
-22% -$1.59M ﹤0.01% 2957
2024
Q3
$10.1M Sell
348,164
-393,884
-53% -$11.5M ﹤0.01% 2610
2024
Q2
$17.2M Sell
742,048
-109,928
-13% -$2.55M ﹤0.01% 2099
2024
Q1
$17.5M Buy
851,976
+393,338
+86% +$8.07M ﹤0.01% 2096
2023
Q4
$9.84M Buy
458,638
+162,844
+55% +$3.49M ﹤0.01% 2435
2023
Q3
$6.1M Buy
295,794
+25,549
+9% +$527K ﹤0.01% 2709
2023
Q2
$7.97M Sell
270,245
-149,591
-36% -$4.41M ﹤0.01% 2494
2023
Q1
$9.67M Buy
419,836
+85,064
+25% +$1.96M ﹤0.01% 2444
2022
Q4
$9.31M Buy
334,772
+114,555
+52% +$3.19M ﹤0.01% 2341
2022
Q3
$6.76M Buy
220,217
+101,150
+85% +$3.1M ﹤0.01% 2563
2022
Q2
$3.5M Sell
119,067
-122,168
-51% -$3.6M ﹤0.01% 3243
2022
Q1
$7.76M Buy
241,235
+112,287
+87% +$3.61M ﹤0.01% 2713
2021
Q4
$5.75M Buy
128,948
+51,102
+66% +$2.28M ﹤0.01% 3009
2021
Q3
$3.93M Buy
77,846
+14,094
+22% +$711K ﹤0.01% 3259
2021
Q2
$5M Buy
63,752
+11,981
+23% +$940K ﹤0.01% 3019
2021
Q1
$2.96M Buy
51,771
+4,477
+9% +$256K ﹤0.01% 3429
2020
Q4
$3.96M Buy
47,294
+18,191
+63% +$1.52M ﹤0.01% 2890
2020
Q3
$1.04M Sell
29,103
-4,307
-13% -$154K ﹤0.01% 3670
2020
Q2
$809K Buy
33,410
+5,801
+21% +$140K ﹤0.01% 3805
2020
Q1
$483K Buy
27,609
+2,565
+10% +$44.9K ﹤0.01% 4013
2019
Q4
$436K Sell
25,044
-18,580
-43% -$323K ﹤0.01% 4377
2019
Q3
$668K Sell
43,624
-37,040
-46% -$567K ﹤0.01% 4154
2019
Q2
$1.68M Sell
80,664
-1,198
-1% -$24.9K ﹤0.01% 3578
2019
Q1
$1.9M Buy
81,862
+64,495
+371% +$1.5M ﹤0.01% 3472
2018
Q4
$359K Buy
17,367
+11,580
+200% +$239K ﹤0.01% 4457
2018
Q3
$126K Buy
5,787
+1,563
+37% +$34K ﹤0.01% 5043
2018
Q2
$64K Buy
4,224
+2,740
+185% +$41.5K ﹤0.01% 5285
2018
Q1
$30K Buy
1,484
+1,200
+423% +$24.3K ﹤0.01% 5487
2017
Q4
$4K Buy
+284
New +$4K ﹤0.01% 5932